Microbial Mechanisms of Pathogenicity
Lecture Overview
Microbial Mechanisms of Pathogenicity
Key Topics Covered:
How Pathogens Cause Disease
Virulence Factors of Bacterial and Viral Pathogens
Virulence Factors of Eukaryotic Pathogens
Source material from: Openstax Microbiology textbook, Chapter 15, Microbial Mechanisms of Pathogenicity
Epidemiological Triangle
Components:
Host Factors: Individual characteristics affecting vulnerability and response to infection.
Immune System: Body's defense mechanisms against pathogens.
Environmental Factors: External conditions influencing the likelihood of transmission and survival of pathogens.
Source: Original host from which the pathogen originates.
Reservoir: Natural habitat where the pathogen survives; can be living or inanimate.
Transmission: Method by which a pathogen is spread from source to host.
Etiological Agent Factors: Characteristics of the pathogen that contribute to disease causation.
Key Definitions
Pathogenicity:
Definition: The ability of an organism to cause disease.
Virulence:
Definition: The degree or severity of pathogenicity exhibited by a pathogen.
Attenuation:
Definition: Loss of virulence factors; the pathogen remains infectious but is weakened.
Virulence Factors (VF):
Definition: Molecules or structures that promote infection and disease, including:
Toxins
Enzymes
Capsules
Functions of Virulence Factors:
Adhesion to host tissues.
Invasion of host tissues.
Direct cell damage.
Evasion of the immune system.
Nutrient acquisition.
Establishing Infection
Infectious Dose (ID):
Definition: The quantity of the microbe necessary to establish an infection in 50% of subjects.
Invasion Process:
Requires specific virulence factors to establish an infection:
Infectious dose of microbe.
Breaking through host defense barriers.
Entry through a portal of entry.
Targeting specific tissues.
Portal of exit for spreading.
How Pathogens Enter the Host
Most pathogens have preferred portals of entry:
Portals of Entry and Exit:
Mucous membranes
Skin
Parenteral route: Deposited directly into tissues through injections, bites, wounds, cuts, surgeries.
Infectious Dose
Infectious Dose (ID50):
The number of cells or virions needed to establish an infection in 50% of subjects.
Lethal Dose (LD50):
The dose that kills 50% of a sample population.
Highly contagious pathogens typically have a low ID50, indicating ease of transmission.
Adherence to Host Cells
First step in pathogenesis following entry.
Pathogens utilize adhesins (ligands) to attach to specific host receptors found on:
Pilus
Fimbriae
Flagella
Glycocalyx
Viral spikes
Biofilms:
A significant factor in adherence; accounts for 60-80% of human infections.
Offers resistance to antibiotics and disinfectants while evading phagocytes by being shielded by an extracellular polymeric substance (EPS).
Establishing Infection: Colonization vs. Invasion
Extracellular Pathogens:
Colonization: Multiplication at the site of infection while remaining outside host cells.
Intracellular Pathogens:
Invasion: Involves penetrating host tissues through the secretion of enzymes or induced endocytosis, multiplying inside host cells. Requires specific invasins as virulence factors.
Examples of Invasion Mechanisms
H. pylori: Uses flagella and urease as invasins to penetrate the stomach lining through mucin layers covering epithelial cells.
Enzymatic Virulence Factors for Infection
Pathogens secrete enzymes to facilitate tissue invasion:
Coagulase: Forms protective fibrin clots around bacteria (e.g., Staphylococcus aureus).
Kinases: Dissolve fibrin clots to spread the infection (e.g., streptokinase, staphylokinase).
Hyaluronidase: Breaks down hyaluronic acid in connective tissue to assist in spreading.
Collagenase: Degrades collagen, leading to tissue breakdown (e.g., in Clostridium perfringens gas gangrene).
IgA protease: Destroys mucosal antibodies, aiding attachment to mucous membranes.
Evasion of Host Defenses
To establish infection, pathogens must overcome:
Physical and Chemical Barriers: (e.g., skin, mucous membranes, lysozymes)
Innate Immune Responses: (e.g., phagocytes, complement system)
Adaptive Immune Responses: (e.g., antibodies, T cells)
Pathogen strategies include:
Avoiding phagocytosis.
Surviving inside phagocytes.
Suppressing or evading immune signaling.
Altering surface antigens (antigenic variation).
Mimicking host molecules.
Strategies to Avoid Phagocytosis
Capsules: Prevent phagocytosis (e.g., Streptococcus pneumoniae, Bacillus anthracis).
Cell wall Components:
M proteins (e.g., from Streptococcus pyogenes) resist phagocytosis.
Mycolic acid (from Mycobacterium tuberculosis) resists digestion within macrophages.
Biofilm Formation: Protects pathogens from antibodies and antibiotics.
Antigenic Variation and Immune Suppression
Antigenic Variation: Surface protein alterations prevent recognition by previously formed antibodies (e.g., Neisseria gonorrhoeae).
Immune Suppression: Pathogens interfere with components of the immune response, such as complement or cytokines.
Intracellular Survival: Pathogens like Listeria monocytogenes and Mycobacterium tuberculosis escape or tolerate phagolysosomal destruction.
Direct Host Damage by Pathogens
Toxins: Molecules that cause adverse effects in the host:
Disrupt normal cell functions and can cause tissue damage.
Types of Toxins:
Endotoxins: Found in the Gram-negative bacterial cell wall – released upon cell death.
Exotoxins: Proteins secreted by bacteria, highly specific, and vary in lethality.
Key Definitions:
Toxigenic: Microbes that produce toxins.
Toxemia: Toxins in the bloodstream.
Intoxication: Presence of toxins without active microbial growth.
Exotoxins: Characteristics and Specifics
Exotoxins:
Definition: Proteins produced and secreted by bacteria, soluble in bodily fluids, destroy host cells and inhibit metabolic functions.
Features: Highly specific for targets, some are lethal.
Term Definitions:
Antitoxins: Antibodies against specific exotoxins providing immunity.
Toxoids: Inactivated exotoxins that can be used in vaccines.
Examples:
Tetanus toxin: from Clostridium tetani
Cholera toxin: from Vibrio cholerae
Neurotoxins: Specifically target neurons.
Enterotoxins: Specifically target the gastrointestinal tract.
Hepatotoxins: Specifically target the liver.
Nephrotoxins: Specifically target the kidneys.
Endotoxins: Properties
Endotoxins:
Definition: Lipopolysaccharides (LPS) found only in the outer membrane of Gram-negative bacteria, released upon cell death.
Lipid A: Triggers intense inflammatory response leading to:
Endotoxic shock or septic shock, characterized by decreased blood pressure, multi-organ failure, and death.
Comparing Endotoxins and Exotoxins
Properties | Endotoxins | Exotoxins |
|---|---|---|
Composition | Lipid | Protein |
Source | Gram-negative bacteria | Gram-negative and Gram-positive bacteria |
Release | From Gram-negative cell wall on division or death | Released actively by growing bacteria |
Mechanism of Action | Causes systemic inflammation | Causes cell toxicity, specific to targets |
Vaccine Target | No | Yes (some) |
Fever-inducing | Yes | Sometimes |
Neutralizable by Antibody | No | Yes (most) |
Toxicity Level | Lower (relatively high LD50) | Higher (many have a low LD50) |
Summary of Bacterial Virulence Factors
Bacterial species exhibit various virulence factors including:
Adhesins for attachment.
Invasins for tissue penetration.
Evasion strategies against the immune system.
Capsules and surface proteins for protection.
Biofilm formation as a defensive strategy against treatments.
Antigenic variation to maintain infection.
Direct cell damage through toxins and secreted enzymes.
Nutrient acquisition strategies like siderophores that sequester iron.
Pathogenic Properties of Viruses
Viral Mechanisms for Evading Host Defenses:
Intracellular location allows viruses to evade detection.
Direct attacks on immune components.
Methylation of viral RNA mimicking host RNA.
Antigenic Variation: Changes in surface proteins that prevent recognition.
Cytopathic Effects (CPE): Visible effects of viral infections which vary by virus and can assist in diagnosis.
Latency: Viruses that remain dormant in the host (e.g., HSV, HIV).
Antigenic Variation in Influenza Virus
Antigenic Drift: Results in small antigenic changes over time due to mutations in genes coding for surface proteins (neuraminidase and hemagglutinin).
Antigenic Shift: Occurs when two different influenza viruses infect a cell simultaneously leading to genetic recombination, resulting in new mixed proteins which can cause pandemics.
Pathogenic Properties of Fungi
Capsules: Help resist phagocytosis (e.g., Cryptococcus neoformans).
Toxins (Mycotoxins): Example: aflatoxin from Aspergillus can lead to liver cancer.
Cell-Wall Components: Trigger inflammation (e.g., Candida albicans).
Proteases: Modify host cell membranes, allowing fungal invasion.
Pathogenic Properties of Protozoa and Helminths
Protozoa:
Exhibit antigenic variation (e.g., Plasmodium, Trypanosoma).
Can reside intracellularly to evade detection (e.g., Toxoplasma gondii).
Direct tissue destruction occurs through feeding and enzyme secretion.
Helminths:
Utilize host tissues for growth and can cause damage through large parasitic masses.
Produce waste products leading to various symptoms.
Learning Objectives
Upon completion of lecture and readings, students should:
Identify the principal portals of entry for pathogens.
Define essential terms such as pathogen, true pathogen, opportunistic pathogen, pathogenicity, and virulence.
Compare the functions of coagulases, kinases, hyaluronidase, and collagenase.
Discuss antigenic variation and provide examples.
Describe invasins and their role in bacterial entry via the host cell cytoskeleton.
Compare and contrast exotoxins and endotoxins.
Define and provide examples of toxin-related terms (antitoxin, toxoid, toxemia, intoxication).
Discuss pathogenic properties of fungi, protozoa, and helminths.